NKGen Biotech (NKGN)
NASDAQ:NKGN
US Market

NKGen Biotech (NKGN) Financial Statements

58 Followers

NKGen Biotech Financial Overview

NKGen Biotech's market cap is currently ―. The company's EPS TTM is $-4.365; its P/E ratio is -0.26; NKGen Biotech is scheduled to report earnings on November 14, 2023, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Dec 22Sep 22
Income Statement-
Total Revenue---$ 0.00$ 0.00
Gross Profit-----
EBIT$ -7.64M$ -45.40M$ -32.97M$ -635.11K$ -404.06K
EBITDA$ -7.31M$ -45.01M$ -32.97M$ -635.11K$ -404.06K
Net Income Common Stockholders$ -5.38M$ -46.82M$ -33.18M$ -3.02M$ 887.57K
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 34.00K$ 26.00K$ 8.80M$ 635.15K$ 728.01K
Total Assets$ 16.32M$ 16.48M$ 25.20M$ 174.37M$ 173.88M
Total Debt$ 20.86M$ 19.92M$ 20.04M$ 0.00$ 0.00
Net Debt$ 20.82M$ 19.89M$ 11.24M$ -635.15K$ -728.01K
Total Liabilities$ 71.37M$ 75.17M$ 65.84M$ 5.37M$ 5.58M
Stockholders Equity$ -55.05M$ -58.69M$ -40.64M$ 168.99M$ 168.29M
Cash Flow-
Free Cash Flow$ -4.00M$ -6.94M$ -13.95M$ -576.50K$ -532.05K
Operating Cash Flow$ -4.03M$ -6.94M$ -13.95M$ -576.50K$ -532.05K
Investing Cash Flow$ 35.00K$ -18.00K$ -113.38M$ 568.64K$ 0.00
Financing Cash Flow$ 4.01M$ -1.80M$ 136.84M$ -85.00K$ 0.00
Currency in USD

NKGen Biotech Earnings and Revenue History

NKGen Biotech Debt to Assets

NKGen Biotech Cash Flow

NKGen Biotech Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis